EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes

Michelle F Jacobs iD, Erika S Koeppe iD, Colby L Chase iD, Julia Martinez, Marie-Louise Henry iD, Jenae M Osborne, Elena M Stoffel iD, Shane C Quinonez iD

Journal of Genetic Counseling · 2024-10 · 33 (5) · 1035-1044

DOI: 10.1002/jgc4.1814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 25.10.2023. Verfasst von Michelle F Jacobs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Genetic Testing, Appointments and Schedules, Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cascade testing, the site‐specific genetic testing of relatives within families with an inherited condition, is underutilized. Long wait times for appointments in specialty genetics clinics are a known barrier to genetic testing access. In our cancer genetics, New Patient Clinic (NPC), the long wait time for an appointment (on average 5 months for routine referrals), was identified by both providers and patients as a barrier to uptake of cascade testing. Timely testing of at‐risk relatives is essential to maximize the benefits of cascade testing and reduce cancer morbidity and mortality. Our objective was to improve access via implementation of a different clinical model that designated appointments for patients seeking cascade testing. A secondary goal was to improve use of genetic counselor time. We implemented a dedicated Cascade Testing Clinic (CTC) with an expedited triaging and unique scheduling model to decrease patient wait time to appointment and optimize clinician time. We report on the process and outcomes here. Between October 2016 and February 2020, the average wait time between referral date and first scheduled appointment date was 46 days for the CTC compared to 144 days for the NPC ( p < 0.0001). No‐show/cancelation/rescheduling rate was 11.7% in the CTC compared to 29.7% in the NPC ( p < 0.0001). Genetic counselors saw approximately twice as many patients per half‐day clinic in the CTC compared to the NPC ( p < 0.00001). Modifications to clinic staffing and appointment times were made based on provider feedback. Implementation of a dedicated clinic specifically for patients seeking cascade testing significantly shortened wait times for this population, reduced patient drop‐off, and improved clinician efficiency. The relatively straightforward indications and generally uncomplicated medical histories made this an ideal population for expedited appointments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingAppointments and SchedulesNeoplastic Syndromes, HereditaryHumansFamilyMaleFemaleAdultMiddle AgedGenetic CounselingTime Factors

Stichwörter der Autor:innen

cancer geneticscascade testinggenetic counselingservice delivery models

Autor:innen und Institutionen

  • Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Rogel Cancer Center, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Pediatric Genetics, Metabolism and Genomic Medicine, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Michelle F Jacobs, Erika S Koeppe, Colby L Chase, Marie-Louise Henry, Elena M Stoffel, Shane C Quinonez

Zitieren

APA

Jacobs, M. F., Koeppe, E. S., Chase, C. L., Martinez, J., Henry, M. L., Osborne, J. M., Stoffel, E. M., & Quinonez, S. C. (2024). Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes. Journal of Genetic Counseling, 33(5), 1035-1044. https://doi.org/10.1002/jgc4.1814

Vancouver

Jacobs MF, Koeppe ES, Chase CL, Martinez J, Henry ML, Osborne JM, et al. Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes. Journal of Genetic Counseling. 2024;33(5):1035-1044. doi:10.1002/jgc4.1814

BibTeX
@article{Jacobs2024,
  author = {Jacobs, Michelle F and Koeppe, Erika S and Chase, Colby L and Martinez, Julia and Henry, Marie-Louise and Osborne, Jenae M and Stoffel, Elena M and Quinonez, Shane C},
  title = {Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes},
  journal = {Journal of Genetic Counseling},
  year = {2024},
  volume = {33},
  number = {5},
  pages = {1035--1044},
  doi = {10.1002/jgc4.1814}
}
Kostenlos starten →